SG Americas Securities’s Icosavax, Inc. Common Stock ICVX Stock Holding History

SG Americas Securities’s Portfolio ICVX Stock Details ICVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-15,502	Closed	-$244K	–	3585
2023 Q4	$244K	Buy	15,502 +963	+7%	+$9.28K	﹤0.01%	1986
2023 Q3	$113K	Buy	+14,539	New	+$121K	﹤0.01%	2716
2021 Q4	–	Sell	-6,041	Closed	-$179K	–	3918
2021 Q3	$179K	Buy	+6,041	New	+$205K	﹤0.01%	3307

SG Americas Securities's ICVX Position: Q1 2024 in Review

SG Americas Securities sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 15,502 shares — an estimated $244K sold.

SG Americas Securities first reported a position in ICVX in Q3 2021 and held it in 3 quarters. The position peaked at $244K in Q4 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

SG Americas Securities reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
SG Americas Securities sold 15,502 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $244K.
SG Americas Securities first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
SG Americas Securities's Icosavax, Inc. Common Stock position peaked at $244K in Q4 2023.
0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on SG Americas Securities's 13F filing for Q1 2024, filed 6 May 2024.